Recently, biventricular or cardiac resynchronization therapy has been shown to improve hemodynamics and symptoms in patients with advanced CHF; however, its utility in patients with AF has not ...

Heart failure (HF) is a growing global health concern, affecting more than 64 million people worldwide. It develops when the heart can no longer pump enough blood to meet the body's demands, often due ...

People may experience different symptoms of heart failure (congestive heart failure) depending on how much of the heart’s pumping capacity has been affected.

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

The pathophysiology of heart failure is complex, but mitochondrial dysfunction is an emerging therapeutic target to improve cardiac function. In this Consensus Statement, insights into the ...

U.S. heart disease mortality has dropped 66% since 1970, mainly due to fewer ischemic heart disease deaths. However, deaths ...

For people with advanced heart failure, left ventricular assist devices, or LVADs, can be a literal lifesaver.

BACKGROUND: Fontan circulatory failure (FCF) is a chronic state in palliated single ventricle heart disease with high morbidity and mortality rates, including heart failure, multisystem end-organ ...

A scientific statement has been published by the ACC regarding the management of obesity in adults with heart failure.

Hospitalized stage C/D HF patients are at increased risk for thromboembolic complications and should receive prophylactic anticoagulation with intravenous unfractionated heparin or low-molecular ...